[go: up one dir, main page]

DK1652843T3 - Amidderivater - Google Patents

Amidderivater

Info

Publication number
DK1652843T3
DK1652843T3 DK04748296.3T DK04748296T DK1652843T3 DK 1652843 T3 DK1652843 T3 DK 1652843T3 DK 04748296 T DK04748296 T DK 04748296T DK 1652843 T3 DK1652843 T3 DK 1652843T3
Authority
DK
Denmark
Prior art keywords
amide derivatives
amide
derivatives
Prior art date
Application number
DK04748296.3T
Other languages
English (en)
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki C O Astellas Pharma Inc Kawano
Akio Kamikawa
Hiroshi C O Astellas Pharma Inc Suzuki
Kenji Sudo
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK1652843T3 publication Critical patent/DK1652843T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
DK04748296.3T 2003-08-08 2004-08-05 Amidderivater DK1652843T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体

Publications (1)

Publication Number Publication Date
DK1652843T3 true DK1652843T3 (da) 2014-05-05

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04748296.3T DK1652843T3 (da) 2003-08-08 2004-08-05 Amidderivater

Country Status (19)

Country Link
US (2) US7465748B2 (da)
EP (1) EP1652843B1 (da)
JP (1) JP4549974B2 (da)
KR (1) KR101157074B1 (da)
CN (1) CN100445271C (da)
AU (1) AU2004263448B2 (da)
BR (1) BRPI0413430B8 (da)
CA (1) CA2535199C (da)
CY (1) CY1115461T1 (da)
DK (1) DK1652843T3 (da)
ES (1) ES2462292T3 (da)
MX (1) MXPA06001526A (da)
NO (1) NO335467B1 (da)
PL (1) PL1652843T3 (da)
PT (1) PT1652843E (da)
RU (1) RU2336273C2 (da)
SI (1) SI1652843T1 (da)
TW (1) TW200505894A (da)
WO (1) WO2005014559A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305648A1 (en) * 2001-12-21 2011-04-06 Novo Nordisk A/S Amide derivatives useful as glucokinase activators
CA2488642C (en) * 2002-06-27 2011-09-06 Dharma Rao Polisetti Aryl carbonyl derivatives as glucokinase activators
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
SI1723128T1 (sl) 2004-01-06 2013-04-30 Transtech Pharma, Inc. Heteroaril uree in njihova uporaba kot aktivatorji glukokinaze
JPWO2006082821A1 (ja) * 2005-02-02 2008-06-26 アステラス製薬株式会社 ヘルペスウイルスが関与する疾患の予防若しくは治療剤
EP1844776B1 (en) * 2005-02-02 2010-04-28 Astellas Pharma Inc. Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
ES2347681T3 (es) * 2005-02-02 2010-11-03 Astellas Pharma Inc. Agentes para tratar el herpes genital despues de su aparicion.
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物
EP1904466A1 (en) * 2005-07-08 2008-04-02 Novo Nordisk A/S Dicycloalkyl urea glucokinase activators
JP2009500378A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー/エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
EP2377856A1 (en) 2005-07-14 2011-10-19 Novo Nordisk A/S Urea glucokinase activators
EP2118083A1 (en) * 2007-01-09 2009-11-18 Novo Nordisk A/S Urea glucokinase activators
CA2675111C (en) 2007-01-11 2016-04-05 Novo Nordisk A\S Urea glucokinase activators
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
EP2263671B1 (en) * 2008-04-02 2016-07-20 Astellas Pharma Inc. Amide derivative-containing pharmaceutical composition
BRPI0912778B1 (pt) * 2008-05-14 2019-04-30 Astellas Pharma Inc. Composto de amida, composição farmacêutica compreendedo dito composto e uso do mesmo para o tratamento de insuficiência renal crônica ou nefropatia diabética
EP2351565A1 (en) 2008-10-20 2011-08-03 Astellas Pharma Inc. Medicine for preventing or treating pain related to herpes zoster
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
EP4487909A3 (en) 2018-06-12 2025-03-19 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
WO2021167840A1 (en) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
ATE227279T1 (de) 1995-12-29 2002-11-15 Boehringer Ingelheim Pharma Phenyl thiazol derivate mit antiherpesvirus eigenschaften
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
WO2000053591A1 (de) * 1999-03-08 2000-09-14 Bayer Aktiengesellschaft Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
EP1185508A2 (en) 1999-05-24 2002-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US6545055B1 (en) 1999-05-24 2003-04-08 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
CA2428184C (en) * 2000-11-10 2010-03-30 Yamanouchi Pharmaceutical Co., Ltd. Thiazolylphenylcarbamoylmethyl amide derivative
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
WO2003095435A1 (en) 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
TWI341311B (da) 2011-05-01
EP1652843B1 (en) 2014-04-02
CN1832930A (zh) 2006-09-13
CA2535199A1 (en) 2005-02-17
US20050032855A1 (en) 2005-02-10
WO2005014559A1 (ja) 2005-02-17
NO20061100L (no) 2006-03-07
PT1652843E (pt) 2014-06-02
US20060229295A1 (en) 2006-10-12
KR20060073928A (ko) 2006-06-29
AU2004263448A1 (en) 2005-02-17
CA2535199C (en) 2010-12-14
RU2006106922A (ru) 2006-08-27
US6903125B2 (en) 2005-06-07
BRPI0413430B1 (pt) 2019-04-30
MXPA06001526A (es) 2006-05-25
CY1115461T1 (el) 2017-01-04
SI1652843T1 (sl) 2014-06-30
BRPI0413430A (pt) 2006-10-17
JPWO2005014559A1 (ja) 2006-10-05
US7465748B2 (en) 2008-12-16
KR101157074B1 (ko) 2012-06-22
RU2336273C2 (ru) 2008-10-20
EP1652843A1 (en) 2006-05-03
BRPI0413430B8 (pt) 2021-05-25
AU2004263448B2 (en) 2009-02-05
EP1652843A4 (en) 2010-07-28
ES2462292T3 (es) 2014-05-22
CN100445271C (zh) 2008-12-24
JP4549974B2 (ja) 2010-09-22
TW200505894A (en) 2005-02-16
NO335467B1 (no) 2014-12-15
PL1652843T3 (pl) 2014-09-30

Similar Documents

Publication Publication Date Title
ATE499347T1 (de) Amidderivate
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE420066T1 (de) Amidoacetonitrilderivate
ATE352550T1 (de) Chinazolinderivate
IS8320A (is) N-staðgengnir pýrasólýl-amidýl-bensimidasólýl
ATE478870T1 (de) Spiroindolinpiperidinderivate
ATE460418T1 (de) Heterocyclocarboxamidderivate
DK1551802T3 (da) Indol-3-svovlderivater
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
DK1652843T3 (da) Amidderivater
IS8180A (is) Nýjar besímídasólafleiður
ATE500227T1 (de) Amidderivate
DE602004019555D1 (de) Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
DK1682129T3 (da) N-thiazol-2-ylbenzamidderivater
ATE423771T1 (de) Tetrahydrochinolinderivate
DK1706373T3 (da) Amidoacetonitrilderivater
IS8045A (is) Púrín-6-ón-afleiður
ATE514681T1 (de) N-substituierte pyrazolylcarboxanilide
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
DK1644316T3 (da) 2-aminobenzoylderivater